Pharmafile Logo

IPF World Week

Roche Basel Switzerland

Roche’s lung cancer drug Alecensa wins EU approval

Monotherapy conditionally approved as second-line NSCLC treatment

- PMLiVE

Innovating patient care

As HCPs and healthcare systems alike strive to provide optimal patient care while managing in an environment that continues to be cost-constrained there is still room to further innovate patient...

- PMLiVE

Intouch Solutions and Healthware International launch joint venture

Intouch Solutions International will be run from London by Ariel Salmang

Deal Watch January 2017

Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

- PMLiVE

New philosophies driving transformative healthcare

The key trends and philosophies driving this disruptive and innovative era of healthcare forward

- PMLiVE

NHS grows digital healthcare professionals network

Six trusts join the 250-strong hospitals currently on the web platform

Roche Basel Switzerland

Tecentriq growth offsets Avastin’s US decline at Roche

Shifts focus to newer therapies in anticipation of brewing biosimilar competition

Sanofi reception

Sanofi/Regeneron bag first approval for Actemra rival sarilumab

Competition to Roche’s blockbuster RA therapy heats up as Canada is first to licence new drug

- PMLiVE

Digital’s ever-changing display of ideas

Creating a coherent strategy to bridge the divide between digital and other elements of the marketing mix.

- PMLiVE

Millennials and health

Why the pharma industry has to reinvent itself to engage with the millennial generation

The rating game

Have we gone too far with online healthcare reviews?

- PMLiVE

2017 Trends Reports

GSW and InVentiv Health Communications are pleased to release the 6th installment of the Trends report series, consisting of four reports: Consumer, Digital, Communications and Healthcare

Syneos Health®

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links